Is it Time to Yank Parkinson’s Drug Nuplazid Off the Market?
Nuplazid (pimavanserin) is an atypical antipsychotic which is approved for the treatment of Parkinson’s disease psychosis and is also being researched for the treatment of…
Tag: Pharmaceutical
FDA Approval of Sackler Clan’s Adhansia XR Raises Some Eyebrows
Certain family names gain notoriety. In the world of drug development (and the opioid crisis), the name Sackler is associated with billions-of-dollars in lawsuits, opioids,…
CHOP 20X Return in 6 years with Roche Acquisition of Spark Therapeutics
Swiss Roche Holding AG recently announced its intension to acquire U.S. biotechnology company Spark Therapeutics Inc. (Spark) as recently reported by NASDAQ. Priced at $4.3…
PharmaWatch: German Boehringer Ingelheim Taking on an American Thorny Thicket
Delaware federal court Judge Richard Lloret recently ordered AbbVie to immediately produce important Humira® documentation to defendant Boehringer Ingelheim (BI) in what is turning out…
Price Watch: Does Sanofi & Regeneron Praluent Price Cut a Harbinger of Things to Come?
Heart disease is the number one killer in America. A few factors contribute to this killer and high cholesterol is a major culprit. According to…
PriceWatch: U.S. Cost of Insulin Nearly Triples from 2012 to 2016
Reuters reported that the cost of insulin for treating type 1 diabetes in the U.S. has nearly doubled over a five-period according to a new…
Pfizer Rumored to be Taking Over Amarin
Global pharma giant Pfizer is rumored to be planning a takeover of biotech Amarin, a biopharmaceutical venture founded in 1993 and headquartered in Bedminster, NJ.…
Kalvista Pharmaceuticals Update
As reported in Citizen Tribune, KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company, focused on the discovery, development, and commercialization of small molecule…
Vertex Pharma Refuses to Supply 3-Year Old with Cystic Fibrosis Drug
The New York Post reports that Scrooge should move over for New England drug maker Vertex. As reported, a Brooklyn family now may spend Christmas…
Novo Nordisk & e-Therapeutics Ink Research Collaboration Deal
Danish drug maker Novo Nordisk and e-Therapeutics have signed a collaboration agreement to leverage the latter’s network-driven drug discovery platform (NDD). This will be for…